Andrew Lo, 10% Owner at Urovant Sciences Ltd. (UROV), bought 29,893 shares at $7.98 ($229K) on 2019-05-20, disclosed to the SEC on 2019-05-20.
Open-market purchase of $229k UROV by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.79 | 5,408 | $37K | 16.0% |
| 2 | $7.36 | 6,200 | $46K | 19.9% |
| 3 | $7.98 | 8,285 | $66K | 28.9% |
| 4 | $7.98 | 8,285 | $66K | 28.9% |
| 5 | $8.39 | 1,715 | $14K | 6.3% |
| Total | $7.66 avg | 29,893 |
| $229K |
| 100% |
| Filing → |
| BBIO | BUY | 2022-01-03 | $99K | — | Filing → |
| UROV | BUY | 2019-06-19 | $303K | — | Filing → |
| UROV | BUY | 2019-06-14 | $355K | — | Filing → |